ANI PHARMACEUTICALS INC

ANIP

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001846487-26-000010
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026
Reporting Owners: Mutz Christopher (HEAD OF RARE DISEASE)
SEC Filing link

Summary

Type

Sell

Net shares

-417

% of shares

-0.40%

Amount (USD)

$30,858

Insider confidence score

51.9 out of 100

Positive

  • Under Rule 10b5-1 trading plan
  • Small scheduled sell (<0.5% of shares)
  • Small sell amount (<$50K)

Stock transactions

Transaction 1

Security

Common Stock

Action

Sell

Date

2026-03-02

Code

S

Net shares

-417.0

Price per Share

$74.00

Amount (USD)

$30,858.00

Acquired/Disposed

Disposed

Shares Owned Before

103,925.0

Shares Owned After

103,508.0

Filing's footnotes

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.

ℹ️ Filed under Rule 10b5-1 trading plan

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.